Back to List View Graph View

Automated Insulin Delivery

Automated insulin delivery (AID) is a diabetes therapy that combines a continuous glucose monitor, an insulin pump, and a control algorithm to adjust insulin delivery in response to measured glucose.

Where the papers sit

10 papers from the last 6 months study Automated Insulin Delivery directly · updated from PubMed 7 Nov 2026

Study type 0 clinical trials · 7 observational · 3 human data

Themes 3 themes

  • Glycemic Outcomes in Type 1 Diabetes

    Time in range, time below range, and hemoglobin A1c remain the core measures of AID effectiveness in type 1 diabetes. Outcomes are increasingly examined in relation to meal composition, menstrual-cycle changes, age, and diabetes distress. Real-world studies of tubeless, Control-IQ, and open-source systems support benefit across varied users, but performance still depends on daily physiological and behavioral context. The field is moving toward more individualized assessment of postprandial and recurrent glycemic patterns.

    5 papers · 50%

  • AID Adoption and Acute Care

    Broader use of AID is being examined across cystic fibrosis-related diabetes, type 1 diabetes, and acute diabetes care. Adoption studies focus on why adults start or discontinue devices, while clinical evaluations track hypoglycemia and diabetes-related acute-care utilization. Tubeless systems are being assessed in routine practice rather than only controlled settings. The main open question is whether wider uptake reduces the burden of acute events across different diabetes populations.

    3 papers · 30%

  • Youth Glycemic Outcomes

    AID research in youth is moving toward identifying which children achieve better glycemic trajectories after initiation. Multicenter analyses extend this question to preschool-age users, where insulin needs, safety, and device uptake require particular attention. Regression models use baseline characteristics, insulin use, and hemoglobin A1c to estimate differences in response. The evidence remains focused on prediction and characterization rather than a settled set of determinants.

    2 papers · 20%

Papers

The 10 papers from the last 6 months that study Automated Insulin Delivery directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Glycemic Outcomes in Type 1 Diabetes (5)
  1. Menstrual cycle-related variations in insulin requirements and glycemic control during automated insulin delivery in adolescents with type 1 diabetes. Journal of pediatric endocrinology & metabolism : JPEM · 28 Aug 2026 PMID 42665003
  2. Real-World Glycemic Outcomes of Open-Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups. Diabetes, obesity & metabolism · 27 Aug 2026 PMID 42660857
  3. Comparison of AID users and non-users regarding glycemic control and diabetes distress: A mixed-methods study. PloS one · 24 Jul 2026 PMID 42497120
  4. Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study. Diabetes, obesity & metabolism · 23 Jul 2026 PMID 42488981
  5. Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal Composition. Diabetes, obesity & metabolism · 20 Jul 2026 PMID 42476949
AID Adoption and Acute Care (3)
  1. Diabetes-related acute care utilization following initiation of automated insulin delivery (AID): A comparison of a disposable tubeless AID system and durable tubed systems. Journal of managed care & specialty pharmacy · 9 Jul 2026 PMID 42424112
  2. Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems. Clinical therapeutics · 16 Jun 2026 PMID 42303551
  3. Adopters and discontinuers: Mapping the diabetes device adoption journeys of adults with type 1 diabetes after continuous glucose monitoring uptake. Patient education and counseling · 28 May 2026 PMID 42208318
Youth Glycemic Outcomes (2)
  1. What Makes the Difference? Predicting Glycemic Trajectories Following Initiation of Automated Insulin Delivery Systems in Youth With Type 1 Diabetes. Diabetes care · 16 Jul 2026 PMID 42461939
  2. Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis. Journal of diabetes science and technology · 23 Jun 2026 PMID 42335144

By study type

Observational studies and case reports (7)
  1. Menstrual cycle-related variations in insulin requirements and glycemic control during automated insulin delivery in adolescents with type 1 diabetes. Journal of pediatric endocrinology & metabolism : JPEM · 28 Aug 2026 PMID 42665003
  2. Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study. Diabetes, obesity & metabolism · 23 Jul 2026 PMID 42488981
  3. Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal Composition. Diabetes, obesity & metabolism · 20 Jul 2026 PMID 42476949
  4. Diabetes-related acute care utilization following initiation of automated insulin delivery (AID): A comparison of a disposable tubeless AID system and durable tubed systems. Journal of managed care & specialty pharmacy · 9 Jul 2026 PMID 42424112
  5. Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis. Journal of diabetes science and technology · 23 Jun 2026 PMID 42335144
  6. Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems. Clinical therapeutics · 16 Jun 2026 PMID 42303551
  7. Adopters and discontinuers: Mapping the diabetes device adoption journeys of adults with type 1 diabetes after continuous glucose monitoring uptake. Patient education and counseling · 28 May 2026 PMID 42208318
Human data, design not indexed (3)
  1. Real-World Glycemic Outcomes of Open-Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups. Diabetes, obesity & metabolism · 27 Aug 2026 PMID 42660857
  2. Comparison of AID users and non-users regarding glycemic control and diabetes distress: A mixed-methods study. PloS one · 24 Jul 2026 PMID 42497120
  3. What Makes the Difference? Predicting Glycemic Trajectories Following Initiation of Automated Insulin Delivery Systems in Youth With Type 1 Diabetes. Diabetes care · 16 Jul 2026 PMID 42461939